Biotech Business Week articles from May 2004

Biotech Business Week archives from May 2004

Aromatase inhibitors may replace tamoxifen.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- A 4-year update of the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial showed that patients on anastrozole have longer disease-free survival, lower incidence of contralateral breast cancer, and...

$1.3M NIH grant awarded to study possible viral role in colon cancer.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- The U.S. National Institutes of Health recently awarded Baylor Research Institute a $1.3 million grant to study a common virus suspected to play a role in causing colon cancer. C. Richard "Rick"...

Study documents cost-effectiveness of HPV test in cervical cancer prevention.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- A new study finds that screening women 30 years of age or older with both a Pap and HPV (human papillomavirus) test reduces cervical cancer incidence by up to 93% and results in a 30% cost savings...

Estrogen research looks for potential cognitive boost.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Just weeks ago the U.S. National Institutes of Health (NIH) announced that estrogen treatment may increase risk of stroke among postmenopausal women. A related study from 2002 linked a therapy...

Immunomedics regains North American development rights for epratuzumab.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) and Amgen, Inc., (AMGN) announced that Amgen has returned to Immunomedics all rights for epratuzumab, the humanized CD22 monoclonal antibody therapeutic licensed to Amgen by...

Nasal lavage may help allergy sufferers.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Last summer, Bill Schroeder's extreme allergies, inflammation, and infection of his sinuses kept him from tending his beloved garden in rural Wisconsin. This year, Schroeder has already begun to...

Researchers link common airborne bacterium to Alzheimer disease.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Researchers at Philadelphia College of Osteopathic Medicine's Center for the Study of Chronic Diseases of Aging in the Adolph and Rose Levis Alzheimer disease Laboratory have found a possible link...

FDA completes review of Propofol IDD-D phase II trial results.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- SkyePharma PLC (SKYE) successfully completed the review of the phase II trial results of Propofol IDD-D with the U.S. Food & Drug Administration. Propofol IDD-D is licensed in North America to Endo...

Oncology company licenses cancer compound to NeoRx.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- AnorMED, Inc., (AOM) announced that it has licensed its platinum-based anticancer agent, AMD473, to NeoRx Corporation (NERX). Under the terms of the agreement, NeoRx was granted exclusive global...

CLEAR II registry launched.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Enzon Pharmaceuticals, Inc., (ENZN) announced a major new initiative to build upon the value of its CLEAR (Collaborative Exchange of Antifungal Research) patient registry with the launch of CLEAR II....

Refinement of MedClose device completed.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Biomed Research, Inc., reported completion of ergonomic refinements to MedClose Internal Puncture Closure Device. The MedClose is a catheter-based debridement and biological glue delivery system...

Role of costimulatory molecules in allergy and asthma reviewed.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Scientists review the role of costimulatory molecules in allergy and asthma in a recent issue of Springer Seminars in Immunopathology. "Activation and differentiation of T cells play a critical...

Xolair forecasted to lead the growth of the asthma drug market in 2012.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., forecasts that Genentech/Novartis/Sankyo/Tanox Biosystems' Xolair will lead the growth of the asthma market with major-market sales of $3.3 billion in 2012. According to...

Collaboration to test theories concerning the mechanism of childhood autism.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Target Discovery Inc. and PrecisionMed Inc. have entered into a research collaboration designed to test competing theories concerning the mechanism of childhood autism. Specifically, the research...

Osteoset DBM Pellets receive U.S. FDA clearance.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Wright Medical Group, Inc., (WMGI) announced that its Osteoset DBM Pellets have been cleared by the U.S. Food and Drug Administration (FDA) for commercial sale to U.S. physicians. The company plans...

Drug development company doses first patient in breast cancer study.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- YM BioSciences Inc. (YM) announced that the first patient has been dosed in its 700-patient phase III registration trial for metastatic breast cancer. The international pivotal trial is designed to...

Progenta breast cancer treatment data presented at cancer research meeting.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Zonagen, Inc., (ZONA) announced that data generated at Zonagen in collaboration with scientists at the University of Illinois-Chicago that indicate the potential for Progenta for the treatment of breast...

Biopharmaceutical company announces plans for CDT platform.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- SCOLR, Inc., (DDD) announced its intention to use its controlled delivery technology (CDT) platform to independently develop a select portfolio of controlled release solid oral medications for...

Business strategy and financial results announced by pharmaceutical company.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Zonagen, Inc., (ZONA) announced that the company's newly elected board of directors together with management have determined that the near-term business strategy for Zonagen is to concentrate its...

Calcitonin licensing and manufacturing agreements announced.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Unigene Laboratories, Inc., (UGNE) has signed licensing and clinical supply agreements with Novartis Pharma AG (NVS) to provide for the recombinant production of calcitonin, the active ingredient used...

Conclusion of joint venture relationship announced.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corporation (TGEN) announced an agreement with Elan Corporation, plc, (ELN) that formally concludes the collaboration between the companies through the joint venture, Emerald Gene...

Pharmaceutical company to close manufacturing facility.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Organon USA Inc., part of the human pharmaceutical business unit of Akzo Nobel, announced its intent to close its West Orange, New Jersey, injectable drug manufacturing facility, effective on or about...

Precision Vascular Systems acquired by device maker; Sentinol launched.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that it has acquired Precision Vascular Systems, Inc., (Precision Vascular), a privately held company located in West Valley City, Utah, and that it has...

Private label demineralized bone matrix distribution agreement announced.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Osteotech, Inc., (OSTE) has entered into a 5-year agreement with Smith & Nephew, Inc.'s, orthopedic division for the processing and distribution of a private label demineralized bone matrix (DBM) to the...

Strategic alliance announced by biopharmaceutical company.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Xechem International Inc. (XKEM) has entered into a memorandum of understanding with Alembic, Limited, and believes the strategic alliance established by this agreement will enhance and accelerate its...

U.S. OTC sales reach $17.5B in 2003, analysis shows.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Preliminary results from the 2003 edition of Kline & Company's Nonprescription Drugs U.S.A annual market analysis indicate that the U.S. market for over-the-counter (OTC) medications grew 5.2% from 2002...

Layoffs confirmed by OxyContin maker.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- OxyContin maker Purdue Pharma confirmed April 13, 2004, that it is laying off about 300 people, or about 9% of its work force, as its mainstay painkiller faces generic competition for the first time....

MIT's Deshpande strikes first funding and licensing deals.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- In the first transactions fulfilling its promise to bridge the gap between university research and commercialization, The Deshpande Center for Technological Innovation at the Massachusetts Institute of...

NeoRx sells Pretarget intellectual property, announces resignation of VP.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- NeoRx Corp. (NERX), a cancer therapeutics development company, announced that it has executed an agreement with privately held Aletheon Pharmaceuticals, Inc., for the sale and transfer of NeoRx's...

Pharmaceutical company presents data at cancer research meeting.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Peregrine Pharmaceuticals, Inc., (PPHM) presented new data at the American Association of Cancer Research annual meeting. The presented research included data related to its tumor necrosis therapy...

U.S. FDA issues agreement for Interleukin 21 phase I cancer study.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- ZymoGenetics (ZGEN) has received agreement from the U.S. Food and Drug Administration (FDA) to begin a phase I clinical study with Interleukin 21 (IL-21), a recombinant human protein being developed by...

Validated cancer SNP assays launched using MGB Eclipse Probe Systems.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Epoch Biosciences, Inc., (EBIO), a provider of proprietary products that accelerate genomic analysis, announced that a new panel of assays targeting single nucleotide polymorphisms (SNPs) identified by...

Partnership to offer regulatory-based cardiac safety monitoring for studies.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) has entered into an agreement with Inveresk, enabling the testing of new drug candidates in conjunction with emerging international cardiac safety regulatory guidance...

Genaissance inks agreements for cardiac tests.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Genaissance Pharmaceuticals, Inc., (GNSC) has signed agreements with the University of Rochester (Minnesota) and the Mayo Foundation for Medical Education and Research, under which Genaissance will...

Role of HDL therapy for cardiovascular disease highlighted in journal.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- An editorial in the April 8, 2004, issue of The New England Journal of Medicine highlighted the role of high-density lipoproteins (HDL) as a new treatment opportunity for cardiovascular disease. ...

Acquisition of central nervous system drugs announced.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Ovation Pharmaceuticals, Inc., has acquired from Aventis, in a cash transaction, the exclusive North American rights for two central nervous system (CNS) pharmaceutical products, Sabril (vigabatrin) and...

Clinical trials extend 3-5 months due to patient recruitment, research shows.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Phase III clinical trials continue an average of 3-5 months longer than initial trial timelines call for, according to new research from pharmaceutical business intelligence firm Cutting Edge...

Agreement signed for HIV molecular diagnostics.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- EraGen Biosciences, a rapidly growing life science company driving a new era in genetic diagnostics and drug discovery, announced they have entered into a collaboration agreement with Emory University...

Agreement signed for Oxygent development in Europe.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Alliance Pharmaceutical Corp. (ALLP), through its wholly owned subsidiary PFC Therapeutics, LLC, and Nycomed announced the signing of a collaboration agreement between PFC Therapeutics and Nycomed for...

Agreement signed with Gilead Sciences for protein activity profiling.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- ActivX Biosciences, Inc., a privately held biotechnology company applying novel chemical technologies and high-throughput protein analysis to drug discovery and development, announced that it has...

Aventis deal expanded to support target validation efforts.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Ardais Corporation, a provider of clinical data and biomaterials resources for molecular medicine-based drug discovery and development, announced that it has expanded its collaborative agreement with...

Brigham & Women's Hospital enters alliance to study neurodegenerative disease.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Chemical Diversity Labs, Inc., (Chemical Diversity) and the Brigham and Women's Hospital (BWH), acting on behalf of the Laboratory for Drug Discovery in Neurodegeneration (LDDN), a Harvard Medical...

Complement inhibition license deal signed with Adprotech.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Avant Immunotherapeutics, Inc., (AVAN) announced the signing of a license agreement with Adprotech, Ltd., for non-exclusive rights to use certain components of Avant's intellectual property surrounding...

Deal signed for promotion of cardiovascular products.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) and Reliant Pharmaceuticals, Inc., announced that the companies have signed an agreement for Amylin to copromote Reliant's cardiovascular products that address...

Distribution agreement signed for Testim 1% testosterone Gel.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Auxilium Pharmaceuticals, Inc., and Ipsen announced that they have entered into a license and distribution agreement for the marketing of Auxilium's product Testim 1% testosterone gel. Under the...

Distribution into Latin America expanded to market SmartCycler.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Cepheid (CPHD) announced that it has signed multiyear distribution agreements with BioAgency Co., Ltd., of Brazil, and Industrias Bioselec S.A. de C.V. of Mexico to market the Cepheid SmartCycler system...

Drug discovery alliance inked with Takeda Chemical Industries.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) announced the commencement of a drug discovery collaboration with Takeda Chemical Industries, Ltd., to create a series of small molecule drug leads against a Takeda target....

Genes To Leads drug discovery contract signed with Novartis.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Cengent Therapeutics, a structure-guided drug discovery company, announced the signing of a Genes To Leads drug discovery contract with the Novartis Institutes for BioMedical Research site in Basel,...

Immunodiagnostics company signs lab supply deal.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Diagnostic Products Corporation (DP) and Premier, Inc., have signed a 1-year, multi-source agreement with an annual renewal option for 2 years. As a result of this agreement, DPC will offer to...

Marketing agreement signed for DepoMorphine in Europe.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- SkyePharma PLC (SKYE) announced that it has entered into a strategic marketing agreement with Medeus Pharma for the marketing and distribution of DepoMorphine in Europe. DepoMorphine is...

Neuroscience firm licenses NMDA receptor NR2B subunit selective antagonists.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Evotec Neurosciences GmbH (ENS), a subsidiary of Evotec OAI AG (EVT), announced that it has acquired from Roche an exclusive worldwide license to develop and market an extensive patent portfolio...

Supply, development agreement signed for medical device batteries.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Advanced Neuromodulation Systems, Inc., (ANS, ANSI) announced a long-term supply agreement with EaglePicher Technologies, LLC, under which EaglePicher will supply ANS with rechargeable lithium ion...

Statement issued regarding FD GMP observations.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Cordis Cardiology, a division of Cordis Corporation, a Johnson & Johnson Company, reported that it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding FDA's...

Approval granted to market a generic version of mirtazapine in Spain.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Bentley Pharmaceuticals, Inc., (BNT) announced that its subsidiaries have been granted approval by the Spanish Ministry of Health to market generic equivalents of mirtazapine in Spain. Laboratorios...

Company receives milestone payment from Sanyko after phase IIA study of CS-917.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Metabasis Therapeutics, Inc., announced it has received a milestone payment of $3.5 million from Sankyo Co., Ltd., (Sankyo) for the successful completion of a second phase IIA trial on CS-917, its...

Improved blood sugar control under supervision does not increase costs.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- A study released by the American Association of Clinical Endocrinologists (AACE) found that patients with diabetes who undergo coronary artery bypass graft (CABG) and have strict blood sugar control...

One in four Medicare diabetics does not get eye exams.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Florida Medical Quality Assurance, Inc., (FMQAI) urges everyone with diabetes to have a dilated eye exam at least once a year to reduce the risk of visual impairment from diabetic retinopathy. The...

Retinal risk assessment technology aids in detection of eye disease.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- EyeTel Imaging, Inc., announced that it has formally launched DigiScope, a U.S. Food and Drug Administration (FDA)-cleared for marketing device that physicians can use to detect early-stage diabetic...

Positron-emitting tracers show potential for tumor imaging.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Positron-emitting tracers show potential for tumor imaging. The "potential of O-[[superscript]11C]methyl-L-tyrosine and O[superscript]18F]fluoromethyl-L-tyrosine as positron-emitting tracers for...

Monitors will be offered to members with congestive heart failure, diabetes.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- American Medical Alert Corp. (AMAC), a national provider of home health monitoring appliances and 24/7 communication services, has been selected to provide remote patient monitoring to Healthfirst, a...

ORALscreen declared suitable for drug enforcement in Japan.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Avitar, Inc., (AVR) received high marks for its ORALscreen instant test for drugs-of-abuse by Forensic Science Laboratory, Osaka Prefectural Police Headquarters, Osaka, Japan. In a recent article...

1 of 1,000 pre-clinical drugs advances to human clinical trials, study shows.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Only 1 out of every 1,000 drug candidates that make it to pre-clinical development is deemed promising enough to advance to human clinical trials, according to new research completed by business...

Company initiates project with F. Hoffmann-La Roche.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Odyssey Thera, Inc., announced an agreement with F. Hoffmann-La Roche, Ltd., to carry out pilot studies aimed at profiling selected Roche compounds across Odyssey Thera, Inc.'s, panels of cell-based...

Halozyme signs manufacturing agreement with Avid Bioservices.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Halozyme Therapeutics, Inc., (HZYM), a therapeutically driven biopharmaceutical company focused on the development and commercialization of recombinant human enzymes, announced it has signed a...

Novel sesquiterpene lactones show promise as antimalarial agents.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- A series of novel lactones with potent antimalarial activity have been developed. According to researchers in Germany, "[f]our sesquiterpene lactones of the pseudo-guaianolide type (helenalin,...

bis-(Papaverine) analogue potent muscle relaxant in vitro.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- A bis-(Papaverine) analogue is shown to be a potent muscle relaxant in vitro. "A new series of N-substituted bis-(tetrahydropapaverine) ring systems have been synthesized in expectation of better...

Screening and drug discovery contract expanded.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- PerkinElmer, Inc., (PKI) has been awarded an expanded contract with AstraZeneca R&D Montreal under which PerkinElmer's High Throughput Screening (HTS) assay technologies will be used in expanded...

Pyrrolopyrimidine a novel and selective MRP1 inhibitor.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- A pyrrolopyrimidine is shown to be a novel and selective multidrug-resistance-associated protein 1 inhibitor. "Multidrug resistance mediated by P-glycoprotein (Pgp) or...

Study confirms basis of epilepsy diagnostic test.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Bionomics Limited announced the publication of its international clinical study involving patients with a form of epilepsy confined to early childhood in the scientific journal, Annals of Neurology. ...

Chiropractors urge Americans to walk 2000 steps per day.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Revitalizing your health could be just steps away, according to the American Chiropractic Association (ACA). While seeking out the latest, trendiest exercise craze can be an intimidating endeavor,...

$4,000,000 cash sale of intellectual property announced.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Xtrana, Inc., (XTRN) announced that its stockholders have approved the previously announced sale of its intellectual property to the Applied Biosystems Group of Applera Corporation (ABI) for $4,000,000...

Biopharmaceutical company announces $20M financing agreement.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Viragen, Inc., (VRA) has entered into purchase agreements for the issuance and sale of $20 million in convertible promissory notes and common stock purchase warrants. The notes, which will be...

Biotech company announces $9.1M private placement of common stock.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that it has placed 8 million shares of common stock with institutional investors at approximately $1.14 per share, for an aggregate purchase price of...

Biotech company reports loss per share of $0.35.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- BioDelivery Sciences International, Inc., (BDSI, BDSIW) announced results for its fiscal year ended December 31, 2003. In 2003, BDSI had revenue of $2.9 million, compared to $828,000 in 2002. Net...

Biotech firm completes $50M series B financing.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Archemix Corp., a biopharmaceutical company focused on developing aptamer therapeutics for the prevention and treatment of acute and chronic human diseases, announced the closing of $50 million Series B...

Biotech firm raises $9M in extension of C round financing.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- AGY Therapeutics, Inc., a privately held biopharmaceutical company, announced that the company has raised $9 million through an extension of its Series C round of financing. Existing Series C...

Biotechnology company announces 2003 financial results.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- StemCells, Inc., (STEM) reported its financial results for the fourth quarter and the year ended December 31, 2003. The company reported a loss of $4,740,000, or $0.13 per share, for the fourth...

Completion of common stock offering announced by pharmaceutical company.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Pharmacyclics, Inc., (PCYC) announced the closing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, which includes shares issued pursuant to the exercise of...

Device firm reports 1Q revenue increase of 340%.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Alltracel Pharmaceuticals Plc, (AP.L), announced that its first quarter 2004 revenue was EUR 857,000, up 340% over first quarter 2003 revenues and more than double last quarter's (Q4 2003) record...

Drug development company raises $4.5 million.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Pro-Pharmaceuticals, Inc., (PRW) has raised approximately $4.5 million, in gross proceeds, from new and existing institutional investors through the private placement of approximately 1.25 million newly...

Drugstore chain store announces fourth quarter and year end revenue increases.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Rite Aid Corporation (RAD) announced financial results for its fourth quarter, ended February 28, 2004. Revenues for the 13-week fourth quarter were $4.4 billion versus revenues of $4.1 billion in...

Fibromyalgia drug maker announces exercise of over-Allotment option.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Cypress Bioscience, Inc., (CYPB) announced that the underwriters of its recently announced public offering have notified Cypress that they will exercise their option to purchase an additional 900,000...

Nanobodies maker closes EUR 25M series B financing.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Ablynx, a developer of therapeutic antibodies (Nanobodies), announced the closing of its EUR 25 million (U.S.$30 million) Series B preferred stock financing. This financing provides Ablynx with the...

New Jersey-based J&J posts 20% profit increase.
May 3, 2004... 2004 MAY 3 - (NewsRx.com & NewsRx.net) -- Health care giant Johnson & Johnson on April 13, 2004, reported a 20% increase in first-quarter profit as soaring sales in all its divisions and favorable currency exchange rates more than offset higher...